Orchestra BioMed Holdings Balance Sheet Health
Financial Health criteria checks 6/6
Orchestra BioMed Holdings has a total shareholder equity of $68.0M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $95.2M and $27.2M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$87.60m |
Equity | US$68.04m |
Total liabilities | US$27.17m |
Total assets | US$95.21m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: OBIO's short term assets ($89.1M) exceed its short term liabilities ($11.2M).
Long Term Liabilities: OBIO's short term assets ($89.1M) exceed its long term liabilities ($16.0M).
Debt to Equity History and Analysis
Debt Level: OBIO is debt free.
Reducing Debt: OBIO had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: OBIO has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: OBIO has sufficient cash runway for 1.8 years if free cash flow continues to reduce at historical rates of 28.9% each year.